FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123644703> ?p ?o ?g. }

• W2123644703 endingPage "61" @default.
• W2123644703 startingPage "955" @default.
• W2123644703 abstract "Preclinical and clinical studies have documented the pharmacological interest in camptothecin derivatives in the treatment of resistant tumors. In particular, topotecan, a water-soluble derivative, exhibited promising activity in pretreated ovarian carcinoma. The present study investigated the pattern of tumor response in two human ovarian carcinoma xenografts and in their cisplatin-resistant sublines characterized by different mechanisms of drug resistance. In IGROV-1/Pt1 cells, cisplatin resistance has been ascribed to a reduced susceptibility to apoptosis as a consequence of p53 mutation and inactivation of its function. In the A2780 cisplatin-resistant subline, which retained the wild-type p53 gene status, the development of resistance has been possibly related to increased cell ability to repair drug-induced DNA damage. The in vivo results of the present study showed that topotecan could overcome the resistance in A2780/CP but not in IGROV-1/Pt1 tumor xenografts. The pattern of tumor response following in vivo topotecan treatment correlated with drug ability to induce apoptosis but not with its in vitro antiproliferative activity. The antitumor efficacy of topotecan in the four tumors reflected a different cell response to drug-induced DNA damage, as suggested by different perturbations of cell cycle progression. Indeed, only in the subline refractory to topotecan in vivo, IGROV-1/Pt1, did we observe a persistent arrest of the cells in the S-phase, resulting in a cytostatic and not a cytotoxic effect, since a low level of apoptosis was induced by the drug. In conclusion, the current results support that determination of drug-induced apoptosis is a useful predictor of tumor response to topotecan in ovarian carcinomas and suggest that p53 gene status may be a critical determinant of cell response to topoisomerase inhibitors." @default.
• W2123644703 created "2016-06-24" @default.
• W2123644703 creator A5033312783 @default.
• W2123644703 creator A5041620597 @default.
• W2123644703 creator A5048820442 @default.
• W2123644703 creator A5052056194 @default.
• W2123644703 creator A5054112956 @default.
• W2123644703 creator A5064897676 @default.
• W2123644703 creator A5070863361 @default.
• W2123644703 creator A5071824275 @default.
• W2123644703 creator A5080261722 @default.
• W2123644703 date "1997-06-01" @default.
• W2123644703 modified "2023-09-26" @default.
• W2123644703 title "Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies." @default.
• W2123644703 cites W1519618894 @default.
• W2123644703 cites W1548887848 @default.
• W2123644703 cites W1566875206 @default.
• W2123644703 cites W1581414347 @default.
• W2123644703 cites W1809024175 @default.
• W2123644703 cites W1867229952 @default.
• W2123644703 cites W1905580151 @default.
• W2123644703 cites W1972483602 @default.
• W2123644703 cites W1976570855 @default.
• W2123644703 cites W2007064404 @default.
• W2123644703 cites W2037670899 @default.
• W2123644703 cites W2043703023 @default.
• W2123644703 cites W2057409012 @default.
• W2123644703 cites W2063892537 @default.
• W2123644703 cites W2071754363 @default.
• W2123644703 cites W2092200570 @default.
• W2123644703 cites W2093467508 @default.
• W2123644703 cites W2102345056 @default.
• W2123644703 cites W2103012321 @default.
• W2123644703 cites W2150525034 @default.
• W2123644703 cites W2154341267 @default.
• W2123644703 cites W2237040806 @default.
• W2123644703 cites W2310715966 @default.
• W2123644703 cites W2417643957 @default.
• W2123644703 cites W32442640 @default.
• W2123644703 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9815771" @default.
• W2123644703 hasPublicationYear "1997" @default.
• W2123644703 type Work @default.
• W2123644703 sameAs 2123644703 @default.
• W2123644703 citedByCount "8" @default.
• W2123644703 countsByYear W21236447032015 @default.
• W2123644703 crossrefType "journal-article" @default.
• W2123644703 hasAuthorship W2123644703A5033312783 @default.
• W2123644703 hasAuthorship W2123644703A5041620597 @default.
• W2123644703 hasAuthorship W2123644703A5048820442 @default.
• W2123644703 hasAuthorship W2123644703A5052056194 @default.
• W2123644703 hasAuthorship W2123644703A5054112956 @default.
• W2123644703 hasAuthorship W2123644703A5064897676 @default.
• W2123644703 hasAuthorship W2123644703A5070863361 @default.
• W2123644703 hasAuthorship W2123644703A5071824275 @default.
• W2123644703 hasAuthorship W2123644703A5080261722 @default.
• W2123644703 hasConcept C114851261 @default.
• W2123644703 hasConcept C121608353 @default.
• W2123644703 hasConcept C147897179 @default.
• W2123644703 hasConcept C190283241 @default.
• W2123644703 hasConcept C202751555 @default.
• W2123644703 hasConcept C207001950 @default.
• W2123644703 hasConcept C2776694085 @default.
• W2123644703 hasConcept C2778239845 @default.
• W2123644703 hasConcept C2779682216 @default.
• W2123644703 hasConcept C2780427987 @default.
• W2123644703 hasConcept C2781209748 @default.
• W2123644703 hasConcept C3019054536 @default.
• W2123644703 hasConcept C502942594 @default.
• W2123644703 hasConcept C54355233 @default.
• W2123644703 hasConcept C55493867 @default.
• W2123644703 hasConcept C86803240 @default.
• W2123644703 hasConcept C98274493 @default.
• W2123644703 hasConceptScore W2123644703C114851261 @default.
• W2123644703 hasConceptScore W2123644703C121608353 @default.
• W2123644703 hasConceptScore W2123644703C147897179 @default.
• W2123644703 hasConceptScore W2123644703C190283241 @default.
• W2123644703 hasConceptScore W2123644703C202751555 @default.
• W2123644703 hasConceptScore W2123644703C207001950 @default.
• W2123644703 hasConceptScore W2123644703C2776694085 @default.
• W2123644703 hasConceptScore W2123644703C2778239845 @default.
• W2123644703 hasConceptScore W2123644703C2779682216 @default.
• W2123644703 hasConceptScore W2123644703C2780427987 @default.
• W2123644703 hasConceptScore W2123644703C2781209748 @default.
• W2123644703 hasConceptScore W2123644703C3019054536 @default.
• W2123644703 hasConceptScore W2123644703C502942594 @default.
• W2123644703 hasConceptScore W2123644703C54355233 @default.
• W2123644703 hasConceptScore W2123644703C55493867 @default.
• W2123644703 hasConceptScore W2123644703C86803240 @default.
• W2123644703 hasConceptScore W2123644703C98274493 @default.
• W2123644703 hasIssue "6" @default.
• W2123644703 hasLocation W21236447031 @default.
• W2123644703 hasOpenAccess W2123644703 @default.
• W2123644703 hasPrimaryLocation W21236447031 @default.
• W2123644703 hasRelatedWork W1551123701 @default.
• W2123644703 hasRelatedWork W1964502819 @default.
• W2123644703 hasRelatedWork W1972483602 @default.
• W2123644703 hasRelatedWork W2005969350 @default.
• W2123644703 hasRelatedWork W2026880745 @default.

• next